A novel growth factor bioavailability-enhanced allograft for use in craniomaxillofacial bone regeneration.

Peel SAF, Terryberry J, Naseri S, Orth CF

Open source

DOI
10.3389/fbioe.2026.1841387
Published
2026
Container
Frontiers in bioengineering and biotechnology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fbioe.2026.1841387,
  title = {A novel growth factor bioavailability-enhanced allograft for use in craniomaxillofacial bone regeneration.},
  author = {Peel SAF and Terryberry J and Naseri S and Orth CF},
  year = {2026},
  journal = {Frontiers in bioengineering and biotechnology},
  doi = {10.3389/fbioe.2026.1841387},
  url = {https://doi.org/10.3389/fbioe.2026.1841387}
}

RIS

TY  - JOUR
TI  - A novel growth factor bioavailability-enhanced allograft for use in craniomaxillofacial bone regeneration.
AU  - Peel SAF
AU  - Terryberry J
AU  - Naseri S
AU  - Orth CF
PY  - 2026
JO  - Frontiers in bioengineering and biotechnology
DO  - 10.3389/fbioe.2026.1841387
UR  - https://doi.org/10.3389/fbioe.2026.1841387
ER  - 

APA

SAF, P., J, T., S, N., & CF, O. (2026). A novel growth factor bioavailability-enhanced allograft for use in craniomaxillofacial bone regeneration.. Frontiers in bioengineering and biotechnology. https://doi.org/10.3389/fbioe.2026.1841387

Source records